![]()
|
|
||||||||
J Biol Chem, Vol. 274, Issue 38, 26691-26696, September 17, 1999
From the Institut de Pharmacologie Moléculaire et Cellulaire,
CNRS UPR 411, 660 route des Lucioles, Sophia Antipolis,
06560 Valbonne, France
TREK-1 is a member of the novel structural class
of K+ channels with four transmembrane segments and
two pore domains in tandem (1, 2). TREK-1 is opened by membrane stretch
and arachidonic acid. It is also an important target for volatile
anesthetics (2, 3). Here we show that internal acidification opens
TREK-1. Indeed, lowering pHi shifts the pressure-activation
relationship toward positive values and leads to channel opening at
atmospheric pressure. The pHi-sensitive region in the carboxyl
terminus of TREK-1 is the same that is critically involved in
mechano-gating as well as arachidonic acid activation. A convergence,
which is dependent on the carboxyl terminus, occurs between mechanical, fatty acids and acidic stimuli. Intracellular acidosis, which occurs
during brain and heart ischemia, will induce TREK-1 opening with
subsequent K+ efflux and hyperpolarization.
The near completion of the sequencing of the nematode
Caenorhabditis elegans genome recently identified more than
80 K+ channel genes divided into three major structural
classes: (i) the inward rectifiers with two
TMS1 and a single P domain;
(ii) the Shaker types with six TMS and a single P domain comprising the
voltage-gated Kvs, the calcium-activated Slo, the calcium-regulated SK,
the Eag/Erg, and the KQT channels; and (iii) the two P types with 4TMS
being the largest structural class (about 50 genes) (4-6). Despite an
overall similar 4TMS/2P structure, the sequence identity between these
channels is very low (less than 30%) (5, 6).
The mammalian family of 4TMS/2P K+ channels comprises
TWIK-1, TWIK-2, TASK-1, TASK-2, TREK-1, and TRAAK (1, 7-11). TWIK-1 and TWIK-2 are widely distributed and encode K+-selective
channels with a characteristic weak inward rectification (8, 11).
TASK-1 is found principally in the pancreas, placenta, lung, brain, and
heart (9, 12, 13). TASK-1 lacks intrinsic voltage sensitivity and is
thus a pure background K+-selective channel. Moreover,
TASK-1 is extremely sensitive to variations of extracellular pH in a
narrow physiological range, with 90% of the maximum current recorded
at pH 7.7 and only 10% at pH 6.7 (9). TASK-2, another background
K+ channel recently isolated from human kidney, shares the
external pH sensitivity of TASK-1 (10). Unlike the other 4TMS/2P
channels, TASK-2 is almost absent from the brain and is mainly
expressed in the kidney. Murine TREK-1 is widely distributed with a
strong expression in the brain and in the heart (1). It is activated by
membrane stretch, by AA as well as inhalational anesthetics, while it
is inhibited by a cAMP-dependent phosphorylation (2, 3).
Interestingly, TREK-1 shares the properties of the Aplysia S-type K+ channel, which is involved in presynaptic
facilitation underlying a simple form of learning (14, 15). TRAAK,
another mouse mechano-gated AA-sensitive 4TMS/2P K+
channel, is only expressed in neuronal tissues including brain, spinal
cord, and retina and lacks sensitivity to cAMP (7, 16).
The mammalian mechano-gated K+ channels that have been
previously described in cardiac myocytes, neurons and epithelial kidney cells (17-30) share the biophysical and pharmacological properties of
TREK-1, including single channel conductance (100 pS at 50 mV in
symmetrical K+), flickery kinetics, voltage dependence,
mechano-gating, and sensitivity to AA (2, 16).
In the present report, we demonstrate that the AA-sensitive
mechano-gated K+ channel TREK-1 is opened by intracellular
acidosis. Mutagenesis experiments identify the carboxyl-terminal region
of TREK-1 as critical for the integration of both mechanical and acidic stimuli.
The cDNA cloning, mutational strategy, cell culture,
transfection, and electrophysiology procedures have been previously
described elsewhere (2, 16). Briefly, murine TREK-1 and TRAAK cDNAs were cloned into pIRES-CD8 vector (1, 7). COS cells were transfected
with the DEAE dextran procedure. The positive cells were visualized
using the anti-CD8 antibody-coated bead method (2). Mutant TREK-1 For whole cell experiments, bath solution (EXT) contained 150 mM NaCl, 5 mM KCl, 3 mM
MgCl2, 1 mM CaCl2, 10 mM Hepes, pH 7.4, with NaOH, and pipette solution (INT)
contained 150 mM KCl, 3 mM MgCl2, 5 mM EGTA, and 10 mM Hepes, pH 7.2, with KOH. The
EXT K+-rich solution contained 150 mM KCl
instead of 150 mM NaCl. The HCO3 TREK-1 cDNA was transiently transfected in COS cells, and
channel activity was recorded using the whole cell patch clamp
configuration. In a cell voltage-clamped at 0 mV, AA superfusion
induces a strong outward current (Fig.
1A). In the same cell,
repetitive application of 90 mM
HCO3 The activation of TREK-1 by the addition of
HCO3
Mechano- or Acid Stimulation, Two Interactive Modes of
Activation of the TREK-1 Potassium Channel*
, and
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
46
was deleted at Thr-368,
89 at Thr-322,
100 at Arg-311,
103 at
Gly-308, and
113 at Val-298. The chimera TRAAK/TREK-1 contained the
core of TRAAK (truncated at Gly-255) and the carboxyl terminus of
TREK-1 (Gly-293 to Thr-368).
solution used to induce
intracellular acidosis (31) was made by substituting 90 mM
NaCl with 90 mM NaHCO3. A K+-rich
HCO3
solution was made by substituting
90 mM KCl with 90 mM KHCO3. For
cell-attached experiments, the EXT solution contained 150 KCl instead
of 150 NaCl, and the pipette contained the EXT solution (150 NaCl). To
induce intracellular acidosis, 90 mM KHCO3 was substituted for KCl (31). CO2-rich solution was prepared by bubbling pure CO2 in an EXT KCl solution (containing 25 mM HCO3
instead of 10 mM Hepes) for 10 min (pH 6.0). The NH4Cl
prepulse EXT solution contained 20 mM NH4Cl
substituting for 20 mM KCl. For inside-out experiments, the
pipette solution was EXT, and the bath solution was INT. For acidic (pH
5.0-6.0) INT solutions, Hepes was substituted with Mes, and for basic
(pH 8.0) INT solution, Hepes was substituted with Tris. Hepes INT
solutions at both acidic and basic pH gave similar results (not shown).
Mechanical stimulation was applied through an open loop pressure
generating system and monitored at the level of the patch pipette
throughout the experiment by a calibrated pressure sensor. This system
provides a stable pressure pulse (16). Pressure-effect relationships
were fitted with Boltzmann equations. AA was dissolved in ethanol at a
concentration of 100 mM, flushed with argon, and kept at
20 °C for 1 week. All chemicals were obtained from Sigma.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
, which produces intracellular
acidification (31, 32), mimics AA stimulation (5.5 ± 0.5-fold
increase, n = 29 at 0 mV). Both AA and
HCO3
are ineffective on control
mock-transfected cells (0.5 ± 0.4, n = 7) (Fig.
1B). Moreover, substitution of 90 mM NaCl by an
equivalent concentration of sodium gluconate does not mimic the
activation of TREK-1 by NaHCO3 (n = 6). The
I-V curve of the current induced by
HCO3
shows a prominent outward going
rectification in physiological K+ conditions and reverses
at the predicted EK+ value of
80
mV (Fig. 1C). When external Na+ is substituted
with K+, the reversal potential shifts to 0 mV, and the
I-V curve remains outwardly rectifying (Fig. 1D).
AA similarly activates TRAAK, while
HCO3
is ineffective (0.9 ± 0.1, n = 17) (Fig. 1E).

View larger version (21K):
[in a new window]
Fig. 1.
Bicarbonate-mediated intracellular acidosis
opens TREK-1 in the whole cell configuration. A, a COS
cell expressing TREK-1 is studied in the whole cell configuration at a
holding potential of 0 mV. Superfusion of 10 µM AA and 90 mM NaHCO3 (substituting NaCl) (as indicated by
horizontal bars), which induces intracellular
acidification, reversibly induces an outward current. Zero current is
indicated by a horizontal dashed line.
B, whole cell recording of a mock (CD8)-transfected COS cell
(same conditions as A). C, I-V curve
of the HCO3
-induced current. The
holding potential is
80 mV, and voltage ramps of 800 ms in duration
are applied from
130 to 100 mV every 10 s. Both control and
HCO3
-rich solutions contain 5 mM K+. D, same cell as C
in the presence of 155 mM K+. E,
whole cell recording of a COS cell expressing TRAAK (same conditions as
A).
is also observed at the single
channel level in the cell-attached patch configuration (n = 13) (Fig.
2A). In this configuration,
the pH of the external solution bathing channels under recording is
clamped by the pipette medium (pH 7.2), and channel modulation is
expected to be due to intracellular effects. In this experiment, the
activity of the mechano-gated channel TREK-1 is recorded both at
atmospheric pressure and during the application of a
66 mm Hg
pressure stimulation (Fig. 2A, inset). At
atmospheric pressure, channel activity (NPo) is very low (0.80 ± 0.22, n = 27). Both the resting and the
pressure-induced activities are reversibly stimulated by the
HCO3
addition (Fig. 2A).
Superfusion of a CO2-rich solution, which also produces a
strong intracellular acidification (32), leads to TREK-1 opening in the
cell-attached patch configuration (n = 15) (Fig.
2B). Again, both basal and stretch-induced activities are
strongly stimulated. The current induced by CO2 is
outwardly rectifying and reverses at
80 mV (Fig. 2B,
inset). Another classical approach to alter
pHi-regulated mechanisms is the NH4Cl prepulse
technique, which relies on the greater membrane permeability for
NH3 than for NH4+ ions (32).
The addition of NH4Cl (producing intracellular
alkalinization) does not affect TREK-1 channel activity, while washout
of NH4Cl (producing intracellular acidosis) strongly
stimulates TREK-1 channel activity (n = 6) (Fig.
2C). The current activated by NH4Cl withdrawal similarly displays a strong outward rectification
(Fig. 2C).

View larger version (17K):
[in a new window]
Fig. 2.
Intracellular acidosis activates TREK-1 in
the cell-attached patch configuration. A, cell-attached
patch from a cell expressing TREK-1. Channel activity is recorded at
atmospheric pressure and during a membrane stretch of
66 mm Hg
(indicated by vertical arrows). The bath solution
contains 155 mM KCl, and the holding potential is 0 mV. The
application of 90 mM HCO3
(substituting KCl) in the bath is indicated by a horizontal bar. The inset shows currents induced by membrane
stretch (
66 mm Hg) in control and during
HCO3
superfusion. Zero current is
indicated by a horizontal dashed line.
B, effects of a CO2-rich solution on a
cell-attached patch from a cell expressing TREK-1 (same conditions as
A). The inset shows I-V curves
performed with voltage ramps of 800 ms in duration from
130 to 100 mV
in control and during CO2 addition (different cell from
B). C, effects of addition and washout of 20 mM NH4Cl (substituting KCl) on a cell-attached
patch from a cell expressing TREK-1 (same conditions as A).
During wash-out of NH4Cl, voltage is stepped to
50 and
+50 mV (as indicated by arrows).
The effects of intracellular acidification were also studied on excised
inside-out patches expressing TREK-1 (Fig.
3). Channel activity was recorded at both
atmospheric pressure and during membrane stretch. Gradual intracellular
acidification from 7.2 to 5.0 induces channel opening at atmospheric
pressure (Fig. 3, A and B). NPo is strongly
increased, while the single channel conductance is gradually decreased
by internal acidosis (Fig. 3B). Half-maximal activation is
induced at pHi 6.0, and a drop of 0.7 pHi unit already
produces a significant increase in channel activity (Fig.
3B). A
42 mm Hg stretch induces a robust channel opening
at intracellular pH between 7.2 and 6.0, although it fails to further
open TREK-1 at pHi 5.0 (Fig. 3A). The
pressure-activity relationship of TREK-1 is presented in Fig.
3C. At physiological intracellular pH 7.2, the
pressure-activity relationship is described by a Boltzmann function
with a pressure required for half-maximal activity
(P0.5) of
36.8 ± 2.1 mm Hg (n = 13). Progressive lowering in pHi gradually
shifts the P0.5 toward positive values, leading
to constitutive channel activity under atmospheric pressure at
pHi 5.0 (Fig. 3, C and D). Half-maximal
effect is observed at pH 5.9 (Fig. 3D).
|
The modulation of channel activity by intracellular acidification was
studied on deleted TREK-1 mutants in the inside-out patch
configuration. We used a protocol including two acidic steps to
pHi 6.0 and 5.0 at both atmospheric pressure and during a
66
mm Hg stretch (Fig. 4, B-D). Lowering internal pH from 7.2 to 6.0 reversibly induces TREK-1 wild type opening at atmospheric pressure and slightly potentiates channel activity during stretch (Fig.
4B). Lowering internal pH to
5.0 further opens TREK-1 at atmospheric pressure with no additional
effect at
66 mm Hg. Deletion of the N-terminal region of TREK-1 does
not alter pHi sensitivity or mechano-gating (n = 5; data not shown). However, serial deletion of the C terminus
progressively impairs TREK-1 activation by pHi (Fig.
4E). Like TREK-1 wild type, at atmospheric pressure,
46
is opened at pH 6.0 and 5.0 (Fig. 4E, second
panel), while the next deletion inward,
89, lacks
activation at pH 6.0 and is only mildly opened at pH 5.0 (Fig. 4, C and
E, third panel). Activation of
89
by a membrane stretch of
66 mm Hg is strongly potentiated at both pH
6.0 and pH 5.0 (Fig. 4, C and E, third panel).
100 is only weakly activated at atmospheric pressure by pH 5.0, and
channel activity induced by a
66 mm Hg stretch is only enhanced at pH
5.0 (Fig. 4E, fourth panel).
103 is
not opened at atmospheric pressure by internal acidification at either
pH 6.0 or pH 5.0, and stimulation of the stretch-induced activity is
only observed at pH 5.0 (Fig. 4, D and E,
fifth panel). No channel activity is detected
with
113 at both pressures and at all pH conditions tested
(n = 7).
|
Progressive deletion of the cytosolic region of TREK-1 shifts the
pressure-activity curve toward more negative values, leading to less
sensitive mutant channels (Fig. 5,
A-C). For instance, the relationship for
103 is about 60 mm Hg more negative compared with that of TREK-1 at pH 7.2 (Figs.
3C and 5C). Lowering pHi to 6.0 and then
5.0 gradually shifts the relationship toward more positive values and
strongly stimulates channel activity elicited by pressure (Figs.
4D and 5C).
|
Unlike TREK-1, TRAAK, the other stretch- and AA-sensitive member of the
4TMS/2P K+ channel family (P0.5 =
46 ± 2 at pH 7.2; n = 7) is quite insensitive to intracellular acidosis (Figs. 1E and
6, A and D).
However, the high pHi sensitivity of TREK-1 can be transferred to TRAAK when the proximal C-terminal regions are exchanged (Fig. 6,
B, C, and E). As observed for TREK-1,
internal acidosis shifts the pressure-activity curve toward positive
values, resulting in the opening of the TRAAK/TREK-1 chimera at
atmospheric pressure (P0.5 =
40 ± 3, n = 7; P0.5 =
32 ± 5, n = 4; P0.5 =
26 ± 3, n = 4, at pH 7.2, 6.0, and 5.0, respectively).
Moreover, HCO3
superfusion induces a
strong stimulation of the whole cell membrane current of the
TRAAK/TREK-1 chimera (3.8 ± 0.4, n = 10),
although it has no effect on TRAAK (0.9 ± 0.1, n = 17) (Fig. 1E).
|
| |
DISCUSSION |
|---|
|
|
|---|
Mammalian mechano-gated K+ channels have been
previously described in atrial and ventricular cardiac myocytes, in
neurons from mesencephalic and hypothalamic areas of the brain as well
as in kidney (17-20, 29). Negative pressure applied to cell-attached patches activates K+ channels (17-20). The pressure to
induce half-maximal activation is between
12 and
18 mm Hg at +40
mV. I-V curves are outwardly rectifying, and single channel
conductances are 94 and 143 picosiemens at +60 mV in symmetrical
K+ for cardiac and brain cells, respectively. Openings
induced by stretch are typically bursty and flickery. The probability
of these channels to open at a fixed pressure is
voltage-dependent with a higher opening at depolarized
potentials. Both cardiac and neuronal channels are similarly opened by
AA and other lipophilic compounds in the micromolar range (17-20). AA
activation is found in cells treated with cyclo-oxygenase and
lipoxygenase inhibitors, indicating that AA itself can directly
activate these channels. Unsaturated fatty acids (linoleic, linolenic,
and docosahexaenoic acids) but not saturated fatty acids also activate
these channels. A very important property of these native mechano-gated
arachidonic-sensitive K+ channels is that they are also
stimulated by lowering cytoplasmic pH over the range 7.2-5.6 (17, 20),
and the channels are more sensitive to pressure at acidic intracellular pH.
Two recently cloned 4TMS/2P channels, TREK-1 and TRAAK (1, 2, 7, 16), have many of the properties of endogenous mechano-gated K+ channels. Both channels are activated by shear stress, cell swelling, and membrane stretch (2, 16). Moreover, TREK-1 and TRAAK are opened by AA, linoleic, linolenic, and docosahexaenoic acids but are resistant to saturated fatty acids (2, 7). The single channel conductance of about 100 pS at +50 mV in symmetrical K+, the outward going rectification, the bursty and flickery openings, and the voltage dependence are identical to described endogenous channels (2, 16-20).
The mechano-gated K+ channel TREK-1 is opened, like native
cardiac and neuronal mechano-sensitive K+ channels
(17-20), by intracellular acidosis. The mechanism by which pHi
variations activate TREK-1 involves a shift of the pressure-activity
curve toward positive pressures, leading to constitutive channel
opening at atmospheric pressure under mild internal acidosis. The
acidic stimulation of TREK-1 was seen in whole cell (mediated by
HCO3
), cell-attached (mediated by
HCO3
, CO2, and
NH4Cl prepulse), and excised inside-out patch configuration (internal acidification), suggesting that protons directly affect channel activity. To our knowledge, TREK-1 is the only cloned K+ channel reported so far to be directly opened by
intracellular acidosis.
TRAAK is significantly (p < 0.05) less sensitive to
stretch (P0.5 =
46 ± 2 mm Hg) (16)
compared with TREK-1 (P0.5 =
36 ± 2 mm
Hg). It is also much less sensitive to pHi variations. This is
a major difference between the two channels, which can now be used to
ascribe a native AA- and mechanosensitive K+ channel to
TREK-1 rather than to TRAAK. Another major difference between TREK-1
and TRAAK is the lack of inhibition by cAMP (7). Phosphorylation of
Ser-333 in the carboxyl terminus of TREK-1 is responsible for the
cAMP-induced down-modulation (2). The possibility that intracellular
acidosis mediates TREK-1 opening via an interaction with the protein
kinase A phosphorylation site, which is not present in the TRAAK
structure, is ruled out, since
89, which lacks Ser-333 and is not
sensitive to cAMP, remains stimulated by low pHi.
Deletion and chimeric analysis indicate that the pHi-sensitive
region of TREK-1 is located in the carboxyl-terminal region between
Val-298 and Thr-368 (
113-
46 region). Further deletion in this
carboxyl-terminal region impairs activation by stretch, AA, and
pHi, demonstrating its critical importance for channel function
(2). The sensitivity to pHi is conferred to TRAAK when the
proximal carboxyl terminus of TREK-1 is exchanged with TRAAK,
demonstrating that the region between
46 and the fourth TMS is
necessary and sufficient to provide pH sensitivity. Progressive
deletions of the carboxyl terminus of TREK-1 show that pHi
sensitivity as well as mechano-gating is gradually altered. These
results indicate that the whole segment (Val-298 to Thr-368) is
probably involved in acidic and stretch modulation and that several
amino acids may indeed be involved.
TREK-1 is modulated by a variety of mechanical stimuli such as stretch, swelling, and shear stress and by a variety of chemical stimuli including AA, ligands producing cAMP-dependent phosphorylation, and acidic stimuli (2, 3). TREK-1 is therefore an example of molecular integrator. Furthermore, mechanical activation of TREK-1 is enhanced by intracellular acidosis, demonstrating that a response to one type of stimulus alters the sensitivity to others.
By integrating multiple stimuli, TREK-1 probably fulfills an essential physiological function in the nervous and cardiovascular systems. Under physiological conditions, effectors of TREK-1 activity are probably stretch, AA, and neurotransmitters or hormones that increase intracellular cAMP (2). It is unlikely that activation of TREK-1 by acidification of the intracellular medium is an important physiological stimulus, although one cannot eliminate transient variations below pHi 7.0 (33).
Protection against an exaggerated cellular Ca2+ invasion is
one of the important roles of several types of K+ channels
(34, 35). This has been particularly well established for the large
conductance Ca2+-activated K+ channels
(KCa2+ channels of the BK type) as well as for
ATP-sensitive K+ channels (KATP channels)
(36-38). When Ca2+ invades a cell, one of the ways to
resist further Ca2+ invasion (which would be deleterious),
from voltage-sensitive Ca2+ channels and/or through NMDA
receptors, is hyperpolarization. Hyperpolarization puts the cell
membrane potential far from the threshold of voltage-sensitive
Ca2+ channel activation and favors the NMDA
receptor-associated Ca2+-permeable channel blockade by
Mg2+. It has been particularly well demonstrated that, when
hypoxia, anoxia, or/and hypoglycemia occur, the associated decrease of intracellular ATP and the related increase of intracellular ADP result
in the activation of KATP channels (34, 35, 39-41). This
activation produced by inhibition of the energetic metabolism is
protective in tissues where the channel is expressed such as in the
heart or brain (35). In conditions of intracellular acidification, which would occur in many physiopathological situations such as brain
or heart ischemia, opening of TREK-1 (KHi channel mode) may
fulfill a similar protective role. TREK-1 channels in the KHi channel mode could work in concert with
KCa2+ (BK type) and KATP channels.
Cellular swelling, which also accompanies ischemia (42), would increase
the effect of intracellular acidification on the activity of the TREK-1
channel (2). Ischemia in heart and brain is associated with a major
K+ efflux (34, 35, 43). This efflux is supposed to be
through K+ channels that open under these conditions (34,
35). However, specific blockers of KCa2+
channels or of KATP channels do not eliminate this efflux
(43, 44). TREK-1 channels may thus constitute an important pathway for
this K+ efflux.
| |
ACKNOWLEDGEMENTS |
|---|
We are grateful to M. Jodar and D. Doume for excellent technical assistance.
| |
FOOTNOTES |
|---|
* This work was supported by the Center National de la Recherche Scientifique, the Association Française contre les Myopathies, the Conseil Régional Provence-Alpes Côte d'Azur, and the European Economic Community Marie-Curie Program (to A. P.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
To whom correspondence should be addressed. Tel.: 33 4 93 95 77 02/03; Fax: 33 4 93 95 77 04; E-mail: ipmc@ipmc.cnrs.fr.
| |
ABBREVIATIONS |
|---|
The abbreviations used are: TMS, transmembrane segment(s); AA, arachidonic acid; Mes, 4-morpholineethanesulfonic acid; NPo, number of channels × open channel probability.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Fink, M., Duprat, F., Lesage, F., Reyes, R., Romey, G., Heurteaux, C., and Lazdunski, M. (1996) EMBO J. 15, 6854-6862[Medline] [Order article via Infotrieve] |
| 2. | Patel, A. J., Honoré, E., Maingret, F., Lesage, F., Fink, M., Duprat, F., and Lazdunski, M. (1998) EMBO J. 17, 4283-4290[CrossRef][Medline] [Order article via Infotrieve] |
| 3. | Patel, A. J., Honoré, E., Lesage, F., Fink, M., Romey, G., and Lazdunski, M. (1999) Nature Neurosci. 2, 422-426[CrossRef][Medline] [Order article via Infotrieve] |
| 4. |
Bargmann, C.
(1998)
Science
282,
2028-2033 |
| 5. | Wei, A., Jegla, T., and Salkoff, L. (1996) Neuropharmacology 35, 805-829[CrossRef][Medline] [Order article via Infotrieve] |
| 6. | Lesage, F., and Lazdunski, M. (1999) in Current Topics in Membranes (Kurachi, Y., ed), Vol. 46 , pp. 199-222, Academic Press, San Diego, CA |
| 7. | Fink, M., Lesage, F., Duprat, F., Heurteaux, C., Reyes, R., Fosset, M., and Lazdunski, M. (1998) EMBO J. 17, 3297-3308[CrossRef][Medline] [Order article via Infotrieve] |
| 8. | Lesage, F., Guillemare, E., Fink, M., Duprat, F., Lazdunski, M., Romey, G., and Barhanin, J. (1996) EMBO J. 15, 1004-1011[Medline] [Order article via Infotrieve] |
| 9. | Duprat, F., Lesage, F., Fink, M., Reyes, R., Heurteaux, C., and Lazdunski, M. (1997) EMBO J. 16, 5464-5471[CrossRef][Medline] [Order article via Infotrieve] |
| 10. |
Reyes, R.,
Duprat, F.,
Lesage, F.,
Fink, M.,
Salinas, M.,
Farman, N.,
and Lazdunski, M.
(1998)
J. Biol. Chem.
273,
30863-30869 |
| 11. |
Chavez, R. A.,
Gray, A. T.,
Zhao, B. B.,
Kindler, C. H.,
Mazurek, M. J.,
Mehta, Y.,
Forsayeth, J. R.,
and Yost, C. S.
(1999)
J. Biol. Chem.
274,
7887-7892 |
| 12. |
Leonoudakis, D.,
Gray, A. T.,
Winegar, B. D.,
Kindler, C. H.,
Harada, M.,
Taylor, D. M.,
Chavez, R. A.,
Forsayeth, J. R.,
and Yost, C. S.
(1998)
J. Neurosci.
18,
868-877 |
| 13. |
Kim, D.,
Fujita, A.,
Horio, Y.,
and Kurachi, Y.
(1998)
Circ. Res.
82,
513-518 |
| 14. | Belardetti, F., and Siegelbaum, S. A. (1988) Trends Neurosci. 11, 232-238[CrossRef][Medline] [Order article via Infotrieve] |
| 15. | Hawkins, R. D., Kandel, E. R., and Siegelbaum, S. A. (1993) Annu. Rev. Neurosci. 16, 625-665[Medline] [Order article via Infotrieve] |
| 16. |
Maingret, F.,
Fosset, M.,
Lesage, F.,
Lazdunski, M.,
and Honoré, E.
(1999)
J. Biol. Chem.
274,
1381-1387 |
| 17. |
Kim, D.
(1992)
J. Gen. Physiol.
100,
1021-1040 |
| 18. |
Kim, D.,
and Clapham, D. E.
(1989)
Science
244,
1174-1176 |
| 19. |
Kim, D.,
and Duff, R. A.
(1990)
Circ. Res.
67,
1040-1046 |
| 20. | Kim, D. H., Sladek, C. D., Aguadovelasco, C., and Mathiasen, J. R. (1995) J. Physiol. (Lond.) 484, 643-660[Medline] [Order article via Infotrieve] |
| 21. | Edwards, K. L., and Pickard, B. G. (1987) in Cell Surface and Signal Transduction (Wagner, E. , Greppin, H. , and Millet, B., eds) , pp. 41-66, Springer-Verlag, Heidelberg |
| 22. | Gustin, M. C. (1992) in Advances in Comparative and Environmental Physiology (Ito, F., ed), Vol. 10 , pp. 19-38, Springer-Verlag, Berlin |
| 23. | Hamill, O. P., and McBride, D., Jr. (1996) Pharmacol. Rev. 48, 231-252[Abstract] |
| 24. | Howard, J., Roberts, W. M., and Hudspeth, A. J. (1988) Annu. Rev. Biophys. Biophys. Chem. 17, 99-124[CrossRef][Medline] [Order article via Infotrieve] |
| 25. | Martinac, B. (1992) in Thermodynamics of Cell Surface Receptors (Jackson, M. B., ed) , pp. 327-352, CRC Press, Inc., Boca Raton, FL |
| 26. | Morris, C. E. (1990) J. Membr. Biol. 113, 93-107[CrossRef][Medline] [Order article via Infotrieve] |
| 27. | Sachs, F. (1988) Crit. Rev. Biomed. Eng. 16, 141-169[Medline] [Order article via Infotrieve] |
| 28. | Sachs, F. (1997) Soc. Gen. Physiol. Ser. 52, 209-218[Medline] [Order article via Infotrieve] |
| 29. | Sackin, H. (1995) Annu. Rev. Physiol. 57, 333-353[Medline] [Order article via Infotrieve] |
| 30. | Sukharev, S. I., Blount, P., Martinac, B., and Kung, C. (1997) Annu. Rev. Physiol. 59, 633-657[CrossRef][Medline] [Order article via Infotrieve] |
| 31. | Fakler, B., Schultz, J. H., Yang, J., Schulte, U., Brandle, U., Zenner, H. P., Jan, L. Y., and Ruppersberg, J. P. (1996) EMBO J. 15, 4093-4099[Medline] [Order article via Infotrieve] |
| 32. | Frelin, C., Vigne, P., Ladoux, A., and Lazdunski, M. (1988) Eur. J. Biochem. 174, 3-14[Medline] [Order article via Infotrieve] |
| 33. | Takahashi, K. I., and Copenhager, D. R. (1996) Neurosci. Res. 24, 109-116[CrossRef][Medline] [Order article via Infotrieve] |
| 34. | Weiss, J. N., and Venkatesh, N. (1993) Cardiovasc. Drugs Ther. 3, 499-505 |
| 35. | Lazdunski, M. (1994) J. Cardiovasc. Pharmacol. 24 Suppl. 4, 1-5[CrossRef][Medline] [Order article via Infotrieve] |
| 36. |
Heurteaux, C.,
Lauritzen, I.,
Widmann, C.,
and Lazdunski, M.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
4666-4670 |
| 37. |
Heurteaux, C.,
Bertaina, V.,
Widmann, C.,
and Lazdunski, M.
(1993)
Proc. Natl. Acad. Sci. U. S. A.
90,
9431-9435 |
| 38. | Lauritzen, I., De Weille, J. R., and Lazdunski, M. (1997) J. Neurochem. 69, 1570-1579[Medline] [Order article via Infotrieve] |
| 39. |
Fosset, M.,
De Weille, J. R.,
Green, R. D.,
Schmid-Antomarchi, H.,
and Lazdunski, M.
(1988)
J. Biol. Chem.
263,
7933-7936 |
| 40. |
Terzic, A.,
Jahangir, A.,
and Kurachi, Y.
(1995)
Am. J. Physiol.
269,
C525-C545 |
| 41. |
Nichols, C. G.,
and Lederer, W. J.
(1991)
Am. J. Physiol.
261,
H1675-H1686 |
| 42. |
Patel, A. J.,
Lauritzen, I.,
Lazdunski, M.,
and Honoré, E.
(1998)
J. Neurosci.
18,
3117-3123 |
| 43. | Shivkumar, K., Deutsch, N. A., Lamp, S. T., Khuu, K., Goldhaber, J. I., and Weiss, J. N. (1997) J. Clin. Invest. 100, 1782-1788[Medline] [Order article via Infotrieve] |
| 44. | Schaeffer, P., and Lazdunski, M. (1990) Brain Res. 539, 155-158 |
This article has been cited by other articles:
![]() |
G. Sandoz, M. P. Tardy, S. Thummler, S. Feliciangeli, M. Lazdunski, and F. Lesage Mtap2 Is a Constituent of the Protein Network That Regulates Twik-Related K+ Channel Expression and Trafficking J. Neurosci., August 20, 2008; 28(34): 8545 - 8552. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Cohen, Y. Ben-Abu, S. Hen, and N. Zilberberg A Novel Mechanism for Human K2P2.1 Channel Gating: FACILITATION OF C-TYPE GATING BY PROTONATION OF EXTRACELLULAR HISTIDINE RESIDUES J. Biol. Chem., July 11, 2008; 283(28): 19448 - 19455. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Heitzmann and R. Warth Physiology and Pathophysiology of Potassium Channels in Gastrointestinal Epithelia Physiol Rev, July 1, 2008; 88(3): 1119 - 1182. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Pokojski, C. Busch, I. Grgic, M. Kacik, W. Salman, R. Preisig-Muller, W.-T. Heyken, J. Daut, J. Hoyer, and R. Kohler TWIK-related two-pore domain potassium channel TREK-1 in carotid endothelium of normotensive and hypertensive mice Cardiovasc Res, April 3, 2008; (2008) cvn069v2. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Hamamoto, J. Marui, K. Matsuoka, K. Higashi, K. Igarashi, T. Nakagawa, T. Kuroda, Y. Mori, Y. Murata, Y. Nakanishi, et al. Characterization of a Tobacco TPK-type K+ Channel as a Novel Tonoplast K+ Channel Using Yeast Tonoplasts J. Biol. Chem., January 25, 2008; 283(4): 1911 - 1920. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Liu, J. A. Enyeart, and J. J. Enyeart Angiotensin II inhibits native bTREK-1 K+ channels through a PLC-, kinase C-, and PIP2-independent pathway requiring ATP hydrolysis Am J Physiol Cell Physiol, August 1, 2007; 293(2): C682 - C695. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Bryan Jr, B. K. Joseph, E. Lloyd, and N. J. Rusch Starring TREK-1: The Next Generation of Vascular K+ Channels Circ. Res., July 20, 2007; 101(2): 119 - 121. [Full Text] [PDF] |
||||
![]() |
M. Magra, S. Hughes, A. J. El Haj, and N. Maffulli VOCCs and TREK-1 ion channel expression in human tenocytes Am J Physiol Cell Physiol, March 1, 2007; 292(3): C1053 - C1060. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ohara, Y. Saeki, M. Nishikawa, Y. Yamamoto, and G. Yamamoto Single-channel Recordings of TREK-1 K+ Channels in Periodontal Ligament Fibroblasts. J. Dent. Res., July 1, 2006; 85(7): 664 - 669. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Honore, A. J. Patel, J. Chemin, T. Suchyna, and F. Sachs Desensitization of mechano-gated K2P channels PNAS, May 2, 2006; 103(18): 6859 - 6864. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kloda, A. Ghazi, and B. Martinac C-Terminal Charged Cluster of MscL, RKKEE, Functions as a pH Sensor Biophys. J., March 15, 2006; 90(6): 1992 - 1998. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Murbartian, Q. Lei, J. J. Sando, and D. A. Bayliss Sequential Phosphorylation Mediates Receptor- and Kinase-induced Inhibition of TREK-1 Background Potassium Channels J. Biol. Chem., August 26, 2005; 280(34): 30175 - 30184. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-S. Kim, J.-Y. Park, H.-W. Kang, E.-J. Lee, H. Bang, and J.-H. Lee Zinc Activates TREK-2 Potassium Channel Activity J. Pharmacol. Exp. Ther., August 1, 2005; 314(2): 618 - 625. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Kang, C. Choe, and D. Kim Thermosensitivity of the two-pore domain K+ channels TREK-2 and TRAAK J. Physiol., April 1, 2005; 564(1): 103 - 116. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Chemin, A. Patel, F. Duprat, M. Zanzouri, M. Lazdunski, and E. Honore Lysophosphatidic Acid-operated K+ Channels J. Biol. Chem., February 11, 2005; 280(6): 4415 - 4421. [Abstract] [Full Text] [PDF] |
||||